Learn more about Afrezza®, the only ultra rapid-acting inhaled insulin. About Afrezza → NO PLANNING Afrezza® lets you inhale your insulin right when food arrives — even unexpectedly — so you can be spontaneous but still in control. NO WAITING Afrezza® lowers your blood sugar fast*,...
AfrezzaAssist® Patient Site AFREZZA, the Afrezza logo, MANNKIND, BLUHALE, BLUHALE PRO, TECHNOSPHERE, AFREZZAASSIST, and the AfrezzaAssist logo are registered trademarks of MannKind. © MannKind Corporation 2024. This site is intended for use by US healthcare professionals only....
and COPD. It is not known if Afrezza® is safe and effective for use in people who smoke. Afrezza® is not for use in people who smoke or have recently stopped smoking (less than 6 months). It is not known if Afrezza® is safe and effective in children under 18 years of age....
这项研究共招募了 141 名患者(其中 123 名是随机招募的),对使用 MDI、胰岛素自动给药系统或无自动给药系统泵的 18 岁以上 T1D 患者进行了分配,让他们继续接受标准护理,或开始接受每日基础注射加 Afrezza 栓注(进餐时和纠正时)的胰岛素治疗方案。使用吸入...
Afrezza是一种新型的粉雾剂和吸入器给药系统,也是一种吸入型速效胰岛素,可有效治疗成人T1MD和T2MD。上述临床试验结果也表明吸入TI是一种有效的降糖药,与现有的餐时皮下注射胰岛素疗效相近。因此,可以认为Afrezza是一种安全、有效、使用方便舒适的替代品。
目前的治疗方法是:注射胰岛素。很不方便。Afrezza也是胰岛素,但它是口服的——准确说是吸入式。 你只需要餐前掏出一个胶囊,放进小小的吸入装置中,不用10秒就搞定。Afrezza的意义在于:让糖尿病患者的生活更方便。 Afrezza的疗效及风险 糖尿病分为I型和II型。Afrezza临床试验结果:针对I型患者疗效不如对照组(采用传统...
美国食品药品监督管理局(FDA)已批准吸入式人胰岛素产品Afrezza(MannKind公司生产)上市,用于改善成年1型和2型糖尿病患者的血糖控制。Afrezza是一种速效吸入式胰岛素,患者可以在餐前或开始进餐后20分钟内使用。但是,Afrezza无法取代长效胰岛素的作用,而且,在1型糖尿病患者中,Afrezza并需与长效胰岛素联合使用。另外,Afrezza不...
Afrezza® can help you with blood sugar control without the need for mealtime injections. Learn how this inhaled insulin works and if it's right for you!
Afrezza is the only inhaled, ultra rapid-acting mealtime insulin that delivers glucose management in the moment for adults living with type 1 or type 2 diabetes. Rapid-Acting insulin Insulin is a hormone stored in the pancreas that helps the body break down glucose (sugar) and turn it into ...